| Cancer Biology and Genomic for Disease Diagnosis |
http://pharmaceuticalintelligence.com/biomed-e-books/cancer-biology-and-genomics-for-disease-diagnosis/ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Title |
Hyperlink |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| The Binding of Oligonucleotides in DNA and 3-D Lattice Structures |
http://pharmaceuticalintelligence.com/2013/05/15/the-binding-of-oligonucleotides-in-dna-and-3-d-lattice-structures/ |
|
|
|
|
|
|
|
| AT13148 – A Novel Oral Multi-AGC Kinase Inhibitor Has Potent Antitumor Activity |
http://pharmaceuticalintelligence.com/2013/05/16/at13148-a-novel-oral-multi-agc-kinase-inhibitor-has-potent-antitumor-activity/ |
|
|
|
|
|
|
| The Development of siRNA-Based Therapies for Cancer |
http://pharmaceuticalintelligence.com/2013/05/09/the-development-of-sirna-based-therapies-for-cancer/ |
|
|
|
|
|
|
|
|
|
| CD47: Target Therapy for Cancer |
http://pharmaceuticalintelligence.com/2013/05/07/cd47-target-therapy-for-cancer/ |
|
|
|
|
|
|
|
|
|
|
| Colon Cancer |
http://pharmaceuticalintelligence.com/2013/04/30/colon-cancer/ |
|
|
|
|
|
|
|
|
|
|
|
|
| Ultrasound-based Screening for Ovarian Cancer |
http://pharmaceuticalintelligence.com/2013/04/28/ultrasound-based-screening-for-ovarian-cancer/ |
|
|
|
|
|
|
|
|
|
| Association between Non-melanoma Skin Cancer and subsequent Primary Cancers in White Population |
http://pharmaceuticalintelligence.com/2013/04/24/association-between-non-melanoma-skin-cancer-and-subsequent-primary-cancers-in-white-population/ |
|
|
|
|
| Tamoxifen’s Effectiveness: Decrease in Tissue Density by Mammography – 50% Lower Risk of Dying from Breast Cancer |
http://pharmaceuticalintelligence.com/2013/04/23/tamoxifens-effectiveness-decrease-in-tissue-density-by-mammography-50-lower-risk-of-dying-from-breast-cancer/ |
|
|
|
| Whole exome somatic mutations analysis of malignant melanoma contributes to the development of personalized cancer therapy for this disease |
http://pharmaceuticalintelligence.com/2013/04/23/whole-exome-somatic-mutations-analysis-of-malignant-melanoma-contributes-to-the-development-of-personalized-cancer-therapy-for-this-disease/ |
|
| DNA Methultransferases – Implications to Epigenetic Regulation and Cancer Therapy Targeting: James Shen, PhD |
http://pharmaceuticalintelligence.com/2013/04/22/dna-methultransferases-implications-to-epigenetic-regulation-and-cancer-therapy-targeting-james-shen-phd/ |
|
|
|
|
| System Pharmacology: Using CellMiner and the NCI-60 Cancerous Cell Lines: William Reinhold, PhD |
http://pharmaceuticalintelligence.com/2013/04/22/system-pharmacology-using-cellminer-and-the-nci-60-cancerous-cell-lines-william-reinhold-phd/ |
|
|
|
|
|
| Genotype-based Analysis for Cancer Therapy using Large-scale Data Modeling: Nayoung Kim, PhD(c) |
http://pharmaceuticalintelligence.com/2013/04/22/genotype-based-analysis-for-cancer-therapy-using-large-scale-data-modeling-nayoung-kim-phdc/ |
|
|
|
|
|
| Molecular Profiling in Cancer Immunotherapy: Debraj GuhaThakurta, PhD |
http://pharmaceuticalintelligence.com/2013/04/22/molecular-profiling-in-cancer-immunotherapy/ |
|
|
|
|
|
|
|
|
|
| Mesothelin: An early detection biomarker for cancer (By Jack Andraka) |
http://pharmaceuticalintelligence.com/2013/04/21/mesothelin-an-early-detection-biomarker-for-cancer-by-jack-andraka/ |
|
|
|
|
|
|
|
| Cancer Genomic Precision Therapy: Digitized Tumor’s Genome (WGSA) Compared with Genome-native Germ Line: Flash-frozen specimen and Formalin-fixed paraffin-embedded Specimen Needed |
http://pharmaceuticalintelligence.com/2013/04/21/cancer-genomic-precision-therapy-digitized-tumors-genome-wgsa-compared-with-genome-native-germ-line-flash-frozen-specimen-and-formalin-fixed-paraffin-embedded-specimen-needed/ |
| Heroes in Medical Research: Dr. Robert Ting, Ph.D. and Retrovirus in AIDS and Cancer |
http://pharmaceuticalintelligence.com/2013/04/17/heroes-in-medical-research-dr-robert-ting-ph-d-and-retrovirus-in-aids-and-cancer/ |
|
|
|
|
|
|
| Critical Gene in Calcium Reabsorption: Variants in the KCNJ and SLC12A1 genes – Calcium Intake and Cancer Protection |
http://pharmaceuticalintelligence.com/2013/04/12/critical-gene-in-calcium-reabsorption-variants-in-the-kcnj-and-slc12a1-genes-calcium-intake-and-cancer-protection/ |
|
|
|
| 2013 American Cancer Research Association Award for Outstanding Achievement in Chemistry in Cancer Research: Professor Alexander Levitzki |
http://pharmaceuticalintelligence.com/2013/04/12/2013-american-cancer-research-association-award-for-outstanding-achievement-in-chemistry-in-cancer-research-professor-alexander-levitzki-chosen/ |
| Pancreatic Cancer: Genetics, Genomics and Immunotherapy |
http://pharmaceuticalintelligence.com/2013/04/11/update-on-pancreatic-cancer/ |
|
|
|
|
|
|
|
|
|
|
|
| Issues in Personalized Medicine in Cancer: Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing |
http://pharmaceuticalintelligence.com/2013/04/10/issues-in-personalized-medicine-in-cancer-intratumor-heterogeneity-and-branched-evolution-revealed-by-multiregion-sequencing/ |
|
|
| Amiodarone Linked to Cancer Risk in Men |
http://pharmaceuticalintelligence.com/2013/04/08/amiodarone-linked-to-cancer-risk-in-men/ |
|
|
|
|
|
|
|
|
|
|
| Beta-Blockers help in better survival in ovarian cancer |
http://pharmaceuticalintelligence.com/2013/04/08/beta-blockers-help-in-better-survival-in-ovarian-cancer/ |
|
|
|
|
|
|
|
|
| Targeting Mitochondrial-bound Hexokinase for Cancer Therapy |
http://pharmaceuticalintelligence.com/2013/04/06/targeting-mitochondrial-bound-hexokinase-for-cancer-therapy/ |
|
|
|
|
|
|
|
|
| zebrafish—susceptible to cancer |
http://pharmaceuticalintelligence.com/2013/04/02/zebrafish-susceptible-to-cancer/ |
|
|
|
|
|
|
|
|
|
|
| Acute Lymphoblastic Leukemia and Bone Marrow Transplantation |
http://pharmaceuticalintelligence.com/2013/03/27/acute-lymphoblastic-leukemia-and-bone-marrow-transplantation/ |
|
|
|
|
|
|
|
| In Focus: Targeting of Cancer Stem Cells |
http://pharmaceuticalintelligence.com/2013/03/27/in-focus-targeting-of-cancer-stem-cells/ |
|
|
|
|
|
|
|
|
|
|
| Ethical Concerns in Personalized Medicine: BRCA1/2 Testing in Minors and Communication of Breast Cancer Risk |
http://pharmaceuticalintelligence.com/2013/03/27/ethical-concerns-in-personalized-medicine-brca12-testing-in-minors-and-communication-of-breast-cancer-risk/ |
|
|
|
|
| Cancer Screening at Sourasky Medical Center Cancer Prevention Center in Tel-Aviv |
http://pharmaceuticalintelligence.com/2013/03/25/tel-aviv-sourasky-medical-center-cancer-prevention-center-excellent-example-for-adopting-prevention-of-cancer-as-a-mean-of-fighting-it/ |
|
| New Ecosystem of Cancer Research: Cross Institutional Team Science |
http://pharmaceuticalintelligence.com/2013/03/24/new-ecosystem-of-cancer-research-cross-institutional-team-science/ |
|
|
|
|
|
|
|
| In Focus: Identity of Cancer Stem Cells |
http://pharmaceuticalintelligence.com/2013/03/22/in-focus-identity-of-cancer-stem-cells/ |
|
|
|
|
|
|
|
|
|
|
| Imaging Guided Cancer-Therapy – a Discipline in Need of Guidance |
http://pharmaceuticalintelligence.com/2013/03/22/imaging-guided-cancer-therapy-a-discipline-in-need-of-guidance/ |
|
|
|
|
|
|
|
|
| How Might Sleep Apnea Lead to Serious Health Concerns like Cardiac and Cancers? |
http://pharmaceuticalintelligence.com/2013/03/20/how-might-sleep-apnea-lead-to-serious-health-concerns-like-cardiac-and-cancers/ |
|
|
|
|
|
|
| The Importance of Cancer Prevention Programs: New Percpectives for Fighting Cancer |
http://pharmaceuticalintelligence.com/2013/03/07/the-importance-of-cancer-prevention-programs-new-perceptions-for-fighting-cancer/ |
|
|
|
|
|
|
| Breast Cancer and Mitochondrial Mutations |
http://pharmaceuticalintelligence.com/2013/03/04/breast-cancer-and-mitochondrial-mutations/ |
|
|
|
|
|
|
|
|
|
| Treatment for Metastatic HER2 Breast Cancer |
http://pharmaceuticalintelligence.com/2013/03/03/treatment-for-metastatic-her2-breast-cancer/ |
|
|
|
|
|
|
|
|
|
| Cancer drugs proving worth |
http://pharmaceuticalintelligence.com/2013/03/02/cancer-drugs-proving-worth/ |
|
|
|
|
|
|
|
|
|
|
|
| recurrence risk for breast cancer |
http://pharmaceuticalintelligence.com/2013/03/02/recurrence-risk-for-breast-cancer/ |
|
|
|
|
|
|
|
|
|
|
| “Thymosin alpha1 and melanoma” |
http://pharmaceuticalintelligence.com/2013/02/15/thymosin-alpha1-in-melanoma/ |
|
|
|
|
|
|
|
|
|
|
| Prostate Cancer: Androgen-driven “Pathomechanism” in Early-onset Forms of the Disease |
http://pharmaceuticalintelligence.com/2013/02/14/prostate-cancer-androgen-driven-pathomechanism-in-early-onset-forms-of-the-disease/ |
|
|
|
|
|
|
| Global Burden of Cancer Treatment & Women Health: Market Access & Cost Concerns |
http://pharmaceuticalintelligence.com/2013/02/10/global-burden-of-cancer-treatment-women-health-market-access-cost-concerns/ |
|
|
|
|
|
|
| Prostate Cancer and Nanotecnology |
http://pharmaceuticalintelligence.com/2013/02/07/prostate-cancer-and-nanotecnology/ |
|
|
|
|
|
|
|
|
|
|
| Winning Over Cancer Progression: New Oncology Drugs to Suppress Passengers Mutations vs. Driver Mutations |
http://pharmaceuticalintelligence.com/2013/02/05/winning-over-cancer-progression-new-oncology-drugs-to-suppress-driver-mutations-vs-passengers-mutations/ |
|
|
|
|
| Hold on. Mutations in Cancer do good |
http://pharmaceuticalintelligence.com/2013/02/04/hold-on-mutations-in-cancer-do-good/ |
|
|
|
|
|
|
|
|
|
|
| State of the art in oncologic imaging of Colorectal cancers |
http://pharmaceuticalintelligence.com/2013/02/02/state-of-the-art-in-oncologic-imaging-of-colorectal-cancers/ |
|
|
|
|
|
|
|
|
| In focus: Triple Negative Breast Cancer |
http://pharmaceuticalintelligence.com/2013/01/29/in-focus-triple-negative-breast-cancer/ |
|
|
|
|
|
|
|
|
|
|
| Novel Cancer Hypothesis Suggests Antioxidants Are Harmful |
http://pharmaceuticalintelligence.com/2013/01/27/novel-cancer-hypothesis-suggests-antioxidants-are-harmful/ |
|
|
|
|
|
|
|
|
| Ovarian Cancer and fluorescence-guided surgery: A report |
http://pharmaceuticalintelligence.com/2013/01/19/ovarian-cancer-and-fluorescence-guided-surgery-a-report/ |
|
|
|
|
|
|
|
|
| Mechanism involved in Breast Cancer Cell Growth: Function in Early Detection & Treatment |
http://pharmaceuticalintelligence.com/2013/01/17/mechanism-involved-in-breast-cancer-cell-growth-function-in-early-detection-treatment/ |
|
|
|
|
|
|
| Role of Primary Cilia in Ovarian Cancer |
http://pharmaceuticalintelligence.com/2013/01/15/role-of-primary-cilia-in-ovarian-cancer-2/ |
|
|
|
|
|
|
|
|
|
|
| Exploring the role of vitamin C in Cancer therapy |
http://pharmaceuticalintelligence.com/2013/01/15/exploring-the-role-of-vitamin-c-in-cancer-therapy/ |
|
|
|
|
|
|
|
|
|
| LEADERS in Genome Sequencing of Genetic Mutations for Therapeutic Drug Selection in Cancer Personalized Treatment: Part 2 |
http://pharmaceuticalintelligence.com/2013/01/13/leaders-in-genome-sequencing-of-genetic-mutations-for-therapeutic-drug-selection-in-cancer-personalized-treatment-part-2/ |
|
|
| Harnessing Personalized Medicine for Cancer Management, Prospects of Prevention and Cure: Opinions of Cancer Scientific Leaders @ http://pharmaceuticalintelligence.com |
http://pharmaceuticalintelligence.com/2013/01/12/harnessing-personalized-medicine-for-cancer-management-prospects-of-prevention-and-cure-opinions-of-cancer-scientific-leaders-httppharmaceuticalintelligence-com/ |
| Inspiration From Dr. Maureen Cronin’s Achievements in Applying Genomic Sequencing to Cancer Diagnostics |
http://pharmaceuticalintelligence.com/2013/01/10/inspiration-from-dr-maureen-cronins-achievements-in-applying-genomic-sequencing-to-cancer-diagnostics/ |
|
|
|
|
| “The Molecular pathology of Breast Cancer Progression” |
http://pharmaceuticalintelligence.com/2013/01/10/the-molecular-pathology-of-breast-cancer-progression/ |
|
|
|
|
|
|
|
|
| The “Cancer establishments” examined by James Watson, co-discoverer of DNA w/Crick, 4/1953 |
http://pharmaceuticalintelligence.com/2013/01/09/the-cancer-establishments-examined-by-james-watson-co-discover-of-dna-wcrick-41953/ |
|
|
|
|
|
|
| New Imaging device bears a promise for better quality control of breast-cancer lumpectomies – considering the cost impact |
http://pharmaceuticalintelligence.com/2013/01/09/new-imaging-device-bears-a-promise-for-better-quality-control-of-breast-cancer-lumpectomies-considering-the-cost-impact/ |
|
|
|
| Not applying evidence-based medicine drives up the costs of screening for breast-cancer in the USA. |
http://pharmaceuticalintelligence.com/2013/01/08/6911/ |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Personalized medicine gearing up to tackle cancer |
http://pharmaceuticalintelligence.com/2013/01/07/personalized-medicine-gearing-up-to-tackle-cancer/ |
|
|
|
|
|
|
|
|
|
| Whole-body imaging as cancer screening tool; answering an unmet clinical need? |
http://pharmaceuticalintelligence.com/2013/01/03/whole-body-imaging-as-cancer-screening-tool-answering-an-unmet-clinical-need/ |
|
|
|
|
|
|
| Stanniocalcin: A Cancer Biomarker. |
http://pharmaceuticalintelligence.com/2012/12/25/stanniocalcin-a-cancer-biomarker/ |
|
|
|
|
|
|
|
|
|
|
| Breast Cancer: Genomic profiling to predict Survival: Combination of Histopathology and Gene Expression Analysis |
http://pharmaceuticalintelligence.com/2012/12/24/breast-cancer-genomic-profiling-to-predict-survival-combination-of-histopathology-and-gene-expression-analysis/ |
|
|
|
| Optical Coherent Tomography – emerging technology in cancer patient management |
http://pharmaceuticalintelligence.com/2012/12/24/optical-coherent-tomography-emerging-technology-in-cancer-patient-management/ |
|
|
|
|
|
|
| Gastric Cancer: Whole-genome reconstruction and mutational signatures |
http://pharmaceuticalintelligence.com/2012/12/24/gastric-cancer-whole-genome-reconstruction-and-mutational-signatures-2/ |
|
|
|
|
|
|
|
| Nanotechnology: Detecting and Treating metastatic cancer in the lymph node |
http://pharmaceuticalintelligence.com/2012/12/19/nanotechnology-detecting-and-treating-metastatic-cancer-in-the-lymph-node/ |
|
|
|
|
|
|
| Nanotech Therapy for Breast Cancer |
http://pharmaceuticalintelligence.com/2012/12/09/naotech-therapy-for-breast-cancer/ |
|
|
|
|
|
|
|
|
|
|
| Dasatinib in Combination With Other Drugs for Advanced, Recurrent Ovarian Cancer |
http://pharmaceuticalintelligence.com/2012/12/08/dasatinib-in-combination-with-other-drugs-for-advanced-recurrent-ovarian-cancer/ |
|
|
|
|
|
|
| Squeezing Ovarian Cancer Cells to Predict Metastatic Potential: Cell Stiffness as Possible Biomarker |
http://pharmaceuticalintelligence.com/2012/12/08/squeezing-ovarian-cancer-cells-to-predict-metastatic-potential-cell-stiffness-as-possible-biomarker/ |
|
|
|
|
|
| BRCA1 a tumour suppressor in breast and ovarian cancer – functions in transcription, ubiquitination and DNA repair |
http://pharmaceuticalintelligence.com/2012/12/04/brca1-a-tumour-suppressor-in-breast-and-ovarian-cancer-functions-in-transcription-ubiquitination-and-dna-repair/ |
|
|
|
| Diagnosing lung cancer in exhaled breath using gold nanoparticles |
http://pharmaceuticalintelligence.com/2012/12/01/diagnosing-lung-cancer-in-exhaled-breath-using-gold-nanoparticles/ |
|
|
|
|
|
|
|
| Personalized Medicine: Cancer Cell Biology and Minimally Invasive Surgery (MIS) |
http://pharmaceuticalintelligence.com/2012/12/01/personalized-medicine-cancer-cell-biology-and-minimally-invasive-surgery-mis/ |
|
|
|
|
|
|
| Prostate Cancer Cells: Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition |
http://pharmaceuticalintelligence.com/2012/11/30/histone-deacetylase-inhibitors-induce-epithelial-to-mesenchymal-transition-in-prostate-cancer-cells/ |
|
|
|
|
|
| PIK3CA mutation in Colorectal Cancer may serve as a Predictive Molecular Biomarker for adjuvant Aspirin therapy |
http://pharmaceuticalintelligence.com/2012/11/28/pik3ca-mutation-in-colorectal-cancer-may-serve-as-a-predictive-molecular-biomarker-for-adjuvant-aspirin-therapy/ |
|
|
|
| Nanotechnology Tackles Brain Cancer |
http://pharmaceuticalintelligence.com/2012/11/23/nanotechnology-tackles-brain-cancer/ |
|
|
|
|
|
|
|
|
|
|
| Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling: a MED12 Control |
http://pharmaceuticalintelligence.com/2012/11/21/response-to-multiple-cancer-drugs-through-regulation-of-tgf-%CE%B2-receptor-signaling-a-med12-control/ |
|
|
|
|
| Personalized medicine-based cure for cancer might not be far away |
http://pharmaceuticalintelligence.com/2012/11/20/personalized-medicine-based-cure-for-cancer-might-not-be-far-away/ |
|
|
|
|
|
|
|
| GSK for Personalized Medicine using Cancer Drugs needs Alacris systems biology model to determine the in silico effect of the inhibitor in its “virtual clinical trial” |
http://pharmaceuticalintelligence.com/2012/11/14/gsk-for-personalized-medicine-using-cancer-drugs-needs-alacris-systems-biology-model-to-determine-the-in-silico-effect-of-the-inhibitor-in-its-virtual-clinical-trial/ |
| Lung Cancer (NSCLC), drug administration and nanotechnology |
http://pharmaceuticalintelligence.com/2012/11/08/lung-cancer-nsclc-drug-administration-and-nanotechnology/ |
|
|
|
|
|
|
|
|
| Non-small Cell Lung Cancer drugs – where does the Future lie? |
http://pharmaceuticalintelligence.com/2012/11/06/non-small-cell-lung-cancer-drugs-where-does-the-future-lie/ |
|
|
|
|
|
|
|
|
| Cancer Innovations from across the Web |
http://pharmaceuticalintelligence.com/2012/11/02/cancer-innovations-from-across-the-web/ |
|
|
|
|
|
|
|
|
|
|
| arrayMap: Genomic Feature Mining of Cancer Entities of Copy Number Abnormalities (CNAs) Data |
http://pharmaceuticalintelligence.com/2012/11/01/arraymap-genomic-feature-mining-of-cancer-entities-of-copy-number-abnormalities-cnas-data/ |
|
|
|
|
|
| How mobile elements in “Junk” DNA promote cancer. Part 1: Transposon-mediated tumorigenesis. |
http://pharmaceuticalintelligence.com/2012/10/31/how-mobile-elements-in-junk-dna-prote-cacner-part1-transposon-mediated-tumorigenesis/ |
|
|
|
|
|
| Cancer Genomics – Leading the Way by Cancer Genomics Program at UC Santa Cruz |
http://pharmaceuticalintelligence.com/2012/10/29/cancer-genomics-leading-the-way-by-cancer-genomics-program-at-uc-santa-cruz/ |
|
|
|
|
|
|
| Closing the gap towards real-time, imaging-guided treatment of cancer patients. |
http://pharmaceuticalintelligence.com/2012/10/27/closing-the-gap-towards-real-time-imaging-guided-treatment-of-cancer-patients/ |
|
|
|
|
|
|
| Lipid Profile, Saturated Fats, Raman Spectrosopy, Cancer Cytology |
http://pharmaceuticalintelligence.com/2012/10/26/lipid-profile-saturated-fats-raman-spectrosopy-cancer-cytology/ |
|
|
|
|
|
|
|
|
| mRNA interference with cancer expression |
http://pharmaceuticalintelligence.com/2012/10/26/mrna-interference-with-cancer-expression/ |
|
|
|
|
|
|
|
|
|
| Pancreatic cancer genomes: Axon guidance pathway genes – aberrations revealed |
http://pharmaceuticalintelligence.com/2012/10/24/pancreatic-cancer-genomes-axon-guidance-pathway-genes-aberrations-revealed/ |
|
|
|
|
|
|
| Biomarker tool development for Early Diagnosis of Pancreatic Cancer: Van Andel Institute and Emory University |
http://pharmaceuticalintelligence.com/2012/10/24/biomarker-tool-development-for-early-diagnosis-of-pancreatic-cancer-van-andel-institute-and-emory-university/ |
|
|
|
|
| The unfortunate ending of the Tower of Babel construction project and its effect on modern imaging-based cancer patients’ management |
http://pharmaceuticalintelligence.com/2012/10/22/the-unfortunate-ending-of-the-tower-of-babel-construction-project-and-its-effect-on-modern-imaging-based-cancer-patients-management/ |
|
| Stomach Cancer Subtypes Methylation-based identified by Singapore-Led Team |
http://pharmaceuticalintelligence.com/2012/10/17/stomach-cancer-subtypes-methylation-based-identified-by-singapore-led-team/ |
|
|
|
|
|
|
| Is the Warburg Effect the cause or the effect of cancer: A 21st Century View? |
http://pharmaceuticalintelligence.com/2012/10/17/is-the-warburg-effect-the-cause-or-the-effect-of-cancer-a-21st-century-view/ |
|
|
|
|
|
|
|
| Crucial role of Nitric Oxide in Cancer |
http://pharmaceuticalintelligence.com/2012/10/16/crucial-role-of-nitric-oxide-in-cancer/ |
|
|
|
|
|
|
|
|
|
|
| Personalized Pancreatic Cancer Treatment Option |
http://pharmaceuticalintelligence.com/2012/10/16/personalized-pancreatic-cancer-treatment-option/ |
|
|
|
|
|
|
|
|
|
| Targeting Glucose Deprived Network Along with Targeted Cancer Therapy Can be a Possible Method of Treatment |
http://pharmaceuticalintelligence.com/2012/10/15/targeting-glucose-deprived-network-along-with-targeted-cancer-therapy-can-be-a-possible-method-of-treatment/ |
|
|
|
| Increased risks of obesity and cancer, Decreased risk of type 2 diabetes: The role of Tumor-suppressor phosphatase and tensin homologue (PTEN) |
http://pharmaceuticalintelligence.com/2012/10/01/increased-risks-of-obesity-and-cancer-decreased-risk-of-type-2-diabetes-the-role-of-tumor-suppressor-phosphatase-and-tensin-homologue-pten/ |
|
| Warning signs may lead to better early detection of ovarian cancer |
http://pharmaceuticalintelligence.com/2012/09/23/warning-signs-may-lead-to-better-early-detection-of-ovarian-cancer/ |
|
|
|
|
|
|
|
| Breast Cancer, drug resistance, and biopharmaceutical targets |
http://pharmaceuticalintelligence.com/2012/09/18/breast-cancer-drug-resistance-and-biopharmaceutical-targets/ |
|
|
|
|
|
|
|
|
| Head and Neck Cancer Studies Suggest Alternative Markers More Prognostically Useful than HPV DNA Testing |
http://pharmaceuticalintelligence.com/2012/09/18/head-and-neck-cancer-studies-suggest-alternative-markers-more-prognostically-useful-than-hpv-dna-testing/ |
|
|
|
|
| Imaging agent to detect Prostate cancer-now a reality |
http://pharmaceuticalintelligence.com/2012/09/18/imaging-agent-to-detect-prostate-cancer-now-a-reality/ |
|
|
|
|
|
|
|
|
| Scientists use natural agents for prostate cancer bone metastasis treatment |
http://pharmaceuticalintelligence.com/2012/09/17/natural-agents-for-prostate-cancer-bone-metastasis-treatment/ |
|
|
|
|
|
|
|
|
| β Integrin emerges as an important player in mitochondrial dysfunction associated Gastric Cancer |
http://pharmaceuticalintelligence.com/2012/09/10/%CE%B2-integrin-emerges-as-an-important-player-in-mitochondrial-dysfunction-associated-gastric-cancer/ |
|
|
|
|
| Comprehensive Genomic Characterization of Squamous Cell Lung Cancers |
http://pharmaceuticalintelligence.com/2012/09/10/comprehensive-genomic-characterization-of-squamous-cell-lung-cancers/ |
|
|
|
|
|
|
|
| Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4 |
http://pharmaceuticalintelligence.com/2012/09/10/targeted-tumor-penetrating-sirna-nanocomplexes-for-credentialing-the-ovarian-cancer-oncogene-id4/ |
|
|
|
|
| Today’s fundamental challenge in Prostate cancer screening |
http://pharmaceuticalintelligence.com/2012/09/02/todays-fundamental-challenge-in-prostate-cancer-screening-2/ |
|
|
|
|
|
|
|
|
| Asthma Drug Prevents Spread of Breast Cancer, Study Finds |
http://pharmaceuticalintelligence.com/2012/09/01/asthma-drug-prevents-spread-of-breast-cancer-study-finds/ |
|
|
|
|
|
|
|
|
| Marijuana Compound Shows Promise In Fighting Breast Cancer |
http://pharmaceuticalintelligence.com/2012/09/01/marijuana-compound-shows-promise-in-fighting-breast-cancer/ |
|
|
|
|
|
|
|
|
| Cell Movement Provides Clues to Aggressive Breast Cancer |
http://pharmaceuticalintelligence.com/2012/09/01/cell-movement-provides-clues-to-aggressive-breast-cancer/ |
|
|
|
|
|
|
|
|
| Identifying Aggressive Breast Cancers by Interpreting the Mathematical Patterns in the Cancer Genome |
http://pharmaceuticalintelligence.com/2012/09/01/identifying-aggressive-breast-cancers-by-interpreting-the-mathematical-patterns-in-the-cancer-genome/ |
|
|
|
|
| Carboranes to aid the ability of the cancer drug |
http://pharmaceuticalintelligence.com/2012/09/01/carboranes-to-aid-the-ability-of-the-cancer-drug/ |
|
|
|
|
|
|
|
|
|
| ROLE OF VIRAL INFECTION IN PROSTATE CANCER |
http://pharmaceuticalintelligence.com/2012/09/01/role-of-viral-infection-in-prostate-cancer/ |
|
|
|
|
|
|
|
|
|
|
| Mitochondria and Cancer: An overview of mechanisms |
http://pharmaceuticalintelligence.com/2012/09/01/mitochondria-and-cancer-an-overview/ |
|
|
|
|
|
|
|
|
|
|
| After Making Millions, Two 20-Somethings Have Founded A Startup To Help Fight Cancer |
http://pharmaceuticalintelligence.com/2012/08/29/after-making-millions-two-20-somethings-have-founded-a-startup-to-help-fight-cancer/ |
|
|
|
|
|
|
| The Incentive for “Imaging based cancer patient’ management” |
http://pharmaceuticalintelligence.com/2012/08/27/the-incentive-for-imaging-based-cancer-patient-management/ |
|
|
|
|
|
|
|
|
| Understand how DNA damage is repaired—knowledge that could result in the development of new and more effective drugs for cancer treatment |
http://pharmaceuticalintelligence.com/2012/08/22/understand-how-dna-damage-is-repaired-knowledge-that-could-result-in-the-development-of-new-and-more-effective-drugs-for-cancer-treatment/ |
|
| Guidelines for the welfare and use of animals in cancer research |
http://pharmaceuticalintelligence.com/2012/08/22/guidelines-for-the-welfare-and-use-of-animals-in-cancer-research/ |
|
|
|
|
|
|
|
|
| Thyroid Cancer: The Evolution of Treatment Options |
http://pharmaceuticalintelligence.com/2012/08/19/thyroid-cancer-the-evolution-of-treatment-options/ |
|
|
|
|
|
|
|
|
|
| “To Die or Not To Die” – Time and Order of Combination drugs for Triple Negative Breast Cancer cells: A Systems Level Analysis |
http://pharmaceuticalintelligence.com/2012/08/15/to-die-or-not-to-die-time-and-order-of-combination-drugs-for-triple-negative-breast-cancer-cells-a-systems-level-analysis/ |
|
|
|
| Missing Gene may drive more than a quarter of Breast Cancers |
http://pharmaceuticalintelligence.com/2012/08/14/missing-gene-may-drive-more-than-a-quarter-of-breast-cancers/ |
|
|
|
|
|
|
|
|
| Aspirin a Day Tied to Lower Cancer Mortality |
http://pharmaceuticalintelligence.com/2012/08/11/1796/ |
|
|
|
|
|
|
|
|
|
|
|
|
|
| $20 million Novartis deal with ‘University of Pennsylvania’ to develop Ultra-Personalized Cancer Immunotherapy |
http://pharmaceuticalintelligence.com/2012/08/08/20-million-novartis-deal-with-university-of-pennsylvania-to-develop-ultra-personalized-cancer-immunotherapy/ |
|
|
|
|
| Prostate Cancers Plunged After USPSTF Guidance, Will It Happen Again? |
http://pharmaceuticalintelligence.com/2012/07/31/prostate-cancers-plunged-after-uspstf-guidance-will-it-happen-again/ |
|
|
|
|
|
|
|
| Medicines in Development for Cancer in 2012: An Excellent Response from America’s Biopharmaceutical Research Companies |
http://pharmaceuticalintelligence.com/2012/07/31/medicines-in-development-for-cancer-in-2012-an-excellent-response-from-americas-biopharmaceutical-research-companies/ |
|
|
| Men With Prostate Cancer More Likely to Die from Other Causes |
http://pharmaceuticalintelligence.com/2012/07/29/men-with-prostate-cancer-more-likely-to-die-from-other-causes/ |
|
|
|
|
|
|
|
|
| Tumor Cells’ Inner Workings Predict Cancer Progression |
http://pharmaceuticalintelligence.com/2012/07/29/tumor-cells-inner-workings-predict-cancer-progression/ |
|
|
|
|
|
|
|
|
| Pfizer’s Kidney Cancer Drug Sutent Effectively caused REMISSION to Adult Acute Lymphoblastic Leukemia (ALL) |
http://pharmaceuticalintelligence.com/2012/07/10/pfizers-kidney-cancer-drug-sutent-effectively-caused-remission-to-adult-acute-lymphoblastic-leukemia-all/ |
|
|
|
|
| Melanoma: Molecule in Immune System Could Help Treat Dangerous Skin Cancer |
http://pharmaceuticalintelligence.com/2012/07/08/melanoma-molecule-in-immune-system-could-help-treat-dangerous-skin-cancer/ |
|
|
|
|
|
|
| Combination Therapy to Starve Cancer Cells to Death |
http://pharmaceuticalintelligence.com/2012/06/29/combination-therapy-to-starve-cancer-cells-to-death/ |
|
|
|
|
|
|
|
|
|
| Cancer and Bone: low magnitude vibrations help mitigate bone loss |
http://pharmaceuticalintelligence.com/2012/06/19/cancer-and-bone-low-magnitude-vibrations-help-mitigate-bone-loss-5-2/ |
|
|
|
|
|
|
|
| HBV and HCV-associated Liver Cancer: Important Insights from the Genome |
http://pharmaceuticalintelligence.com/2012/06/04/hbv-and-hcv-associated-liver-cancer-important-insights-from-the-genome/ |
|
|
|
|
|
|
|
| New Anti-Cancer Drug Developed |
http://pharmaceuticalintelligence.com/2012/05/30/new-anti-cancer-drug-developed/ |
|
|
|
|
|
|
|
|
|
|
| Commonly Used Painkillers May Protect Against Skin Cancer |
http://pharmaceuticalintelligence.com/2012/05/30/commonly-used-painkillers-may-protect-against-skin-cancer/ |
|
|
|
|
|
|
|
|
| New Prostate Cancer Screening Guidelines Face a Tough Sell, Study Suggests |
http://pharmaceuticalintelligence.com/2012/05/27/new-prostate-cancer-screening-guidelines-face-a-tough-sell-study-suggests/ |
|
|
|
|
|
|
|
| Sleep Apnea Might Cause Serious Health Concerns like Cardiac and Cancers |
http://pharmaceuticalintelligence.com/2012/05/22/sleep-apnea-might-cause-serious-health-concerns-like-cardiac-and-cancers/ |
|
|
|
|
|
|
|
| Battle of Steve Jobs and Ralph Steinman with Pancreatic cancer: How we lost |
http://pharmaceuticalintelligence.com/2012/05/21/battle-of-steve-jobs-and-ralph-steinman-with-pancreatic-cancer-how-we-lost/ |
|
|
|
|
|
|
|
| Early Biomarker for Pancreatic Cancer Identified |
http://pharmaceuticalintelligence.com/2012/05/17/early-biomarker-for-pancreatic-cancer-identified/ |
|
|
|
|
|
|
|
|
|
| All Cancer Cells Are Not Created Equal: Some Cell Types Control Continued Tumor Growth, Others Prepare the Way for Metastasis |
http://pharmaceuticalintelligence.com/2012/05/17/all-cancer-cells-are-not-created-equal-some-cell-types-control-continued-tumor-growth-others-prepare-the-way-for-metastasis/ |
|
|
| High Doses of Certain Dietary Supplements Increase Cancer Risk |
http://pharmaceuticalintelligence.com/2012/05/17/high-doses-of-certain-dietary-supplements-increase-cancer-risk/ |
|
|
|
|
|
|
|
|
| Usp9x: Promising therapeutic target for pancreatic cancer |
http://pharmaceuticalintelligence.com/2012/05/14/promising-therapeutic-target-discovered-for-pancreatic-cancer/ |
|
|
|
|
|
|
|
|
| A Strategy to Handle the Most Aggressive Breast Cancer: Triple-negative Tumors |
http://pharmaceuticalintelligence.com/2012/05/12/a-strategy-to-handle-the-most-aggressive-breast-cancer-triple-negative-tumors/ |
|
|
|
|
|
|
| Arthritis, Cancer: New Screening Technique Yields Elusive Compounds to Block Immune-Regulating Enzyme |
http://pharmaceuticalintelligence.com/2012/05/11/arthritis-cancer-new-screening-technique-yields-elusive-compounds-to-block-immune-regulating-enzyme/ |
|
|
|
|
| Dimming ovarian cancer growth |
http://pharmaceuticalintelligence.com/2012/05/11/259/ |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mystery unveiled about Missing breast cancer genes |
http://pharmaceuticalintelligence.com/2012/05/11/mystery-unveiled-about-missing-breast-cancer-genes/ |
|
|
|
|
|
|
|
|
|
| Researchers develop cancer cell-screening biochip to understand the efficacy of especially anti-cancer drugs against CSCs. |
http://pharmaceuticalintelligence.com/2012/05/09/researchers-develop-cancer-cell-screening-biochip-to-understand-the-efficacy-of-especially-anti-cancer-drugs-against-cscs/ |
|
|
|
| ‘Mosaicism’ is Associated with Aging and Chronic Diseases like Cancer: detection of genetic mosaicism could be an early marker for detecting cancer. |
http://pharmaceuticalintelligence.com/2012/05/08/mosaicism-is-associated-with-aging-and-chronic-diseases-like-cancer-detection-of-genetic-mosaicism-could-be-an-early-marker-for-detecting-cancer/ |
| Visualizing breast cancer without X-rays |
http://pharmaceuticalintelligence.com/2012/05/08/visualizing-breast-cancer-without-x-rays/ |
|
|
|
|
|
|
|
|
|
|
| 10 Facts About Cancer |
http://pharmaceuticalintelligence.com/2012/05/08/10-facts-about-cancer/ |
|
|
|
|
|
|
|
|
|
|
|
| What is Cancer? |
http://pharmaceuticalintelligence.com/2012/05/07/what-is-cancer/ |
|
|
|
|
|
|
|
|
|
|
|
|
2012pharmaceutical
Amandeep Kaur
Aashir Awan, Phd
Abhisar Anand
Adina Hazan
Alan F. Kaul, PharmD., MS, MBA, FCCP
alexcrystal6
anamikasarkar
apreconasia
aviralvatsa
David Orchard-Webb, PhD
danutdaagmailcom
Demet Sag, Ph.D., CRA, GCP
Dror Nir
dsmolyar
Ethan Coomber
evelinacohn
Gail S Thornton
Irina Robu
jayzmit48
jdpmd
jshertok
kellyperlman
Ed Kislauskis
larryhbern
Madison Davis
marzankhan
megbaker58
ofermar2020
Dr. Pati
pkandala
Rosalind Codrington, PhD
ritusaxena
Rick Mandahl
sjwilliamspa
Srinivas Sriram
stuartlpbi
Dr. Sudipta Saha
tildabarliya
vaishnavee24
zraviv06
zs22
This is very insightful. There is no doubt that there is the bias you refer to. 42 years ago, when I was postdocing in biochemistry/enzymology before completing my residency in pathology, I knew that there were very influential mambers of the faculty, who also had large programs, and attracted exceptional students. My mentor, it was said (although he was a great writer), could draft a project on toilet paper and call the NIH. It can’t be true, but it was a time in our history preceding a great explosion. It is bizarre for me to read now about eNOS and iNOS, and about CaMKII-á, â, ã, ä – isoenzymes. They were overlooked during the search for the genome, so intermediary metabolism took a back seat. But the work on protein conformation, and on the mechanism of action of enzymes and ligand and coenzyme was just out there, and became more important with the research on signaling pathways. The work on the mechanism of pyridine nucleotide isoenzymes preceded the work by Burton Sobel on the MB isoenzyme in heart. The Vietnam War cut into the funding, and it has actually declined linearly since.
A few years later, I was an Associate Professor at a new Medical School and I submitted a proposal that was reviewed by the Chairman of Pharmacology, who was a former Director of NSF. He thought it was good enough. I was a pathologist and it went to a Biochemistry Review Committee. It was approved, but not funded. The verdict was that I would not be able to carry out the studies needed, and they would have approached it differently. A thousand young investigators are out there now with similar letters. I was told that the Department Chairmen have to build up their faculty. It’s harder now than then. So I filed for and received 3 patents based on my work at the suggestion of my brother-in-law. When I took it to Boehringer-Mannheim, they were actually clueless.